FONAR (FONR) Revenue & Revenue Breakdown
FONAR Revenue Highlights
Latest Revenue (Y)
$98.65M
Latest Revenue (Q)
$25.72M
FONAR Revenue by Period
FONAR Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-06-30 | $98.65M | 1.08% |
| 2022-06-30 | $97.59M | 8.52% |
| 2021-06-30 | $89.93M | 4.95% |
| 2020-06-30 | $85.69M | -1.72% |
| 2019-06-30 | $87.19M | 6.96% |
| 2018-06-30 | $81.52M | 4.46% |
| 2017-06-30 | $78.04M | 6.36% |
| 2016-06-30 | $73.37M | 6.25% |
| 2015-06-30 | $69.05M | 0.80% |
| 2014-06-30 | $68.51M | 39.40% |
| 2013-06-30 | $49.14M | 24.58% |
| 2012-06-30 | $39.44M | 19.04% |
| 2011-06-30 | $33.14M | 4.15% |
| 2010-06-30 | $31.82M | -19.91% |
| 2009-06-30 | $39.72M | 11.68% |
| 2008-06-30 | $35.57M | 7.10% |
| 2007-06-30 | $33.21M | 0.41% |
| 2006-06-30 | $33.08M | -68.47% |
| 2005-06-30 | $104.90M | 46.49% |
| 2004-06-30 | $71.61M | 35.39% |
| 2003-06-30 | $52.89M | 18.38% |
| 2002-06-30 | $44.68M | -3.83% |
| 2001-06-30 | $46.46M | 18.90% |
| 2000-06-30 | $39.07M | 5.89% |
| 1999-06-30 | $36.90M | 33.70% |
| 1998-06-30 | $27.60M | 56.82% |
| 1997-06-30 | $17.60M | 34.35% |
| 1996-06-30 | $13.10M | -7.09% |
| 1995-06-30 | $14.10M | -8.44% |
| 1994-06-30 | $15.40M | -8.33% |
| 1993-06-30 | $16.80M | - |
FONAR generated $98.65M in revenue during NA 2023, up 1.08% compared to the previous quarter, and up 121.01% compared to the same period a year ago.
FONAR Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $25.72M | 1.31% |
| 2023-12-31 | $25.39M | 1154.87% |
| 2023-09-30 | $2.02M | -92.15% |
| 2023-06-30 | $25.78M | 1.39% |
| 2023-03-31 | $25.42M | 4.81% |
| 2022-12-31 | $24.26M | 4.59% |
| 2022-09-30 | $23.19M | -6.53% |
| 2022-06-30 | $24.81M | 0.98% |
| 2022-03-31 | $24.57M | 0.38% |
| 2021-12-31 | $24.48M | 3.16% |
| 2021-09-30 | $23.73M | -3.91% |
| 2021-06-30 | $24.70M | 6.95% |
| 2021-03-31 | $23.09M | 9.10% |
| 2020-12-31 | $21.16M | 0.88% |
| 2020-09-30 | $20.98M | 0.83% |
| 2020-06-30 | $20.81M | -4.06% |
| 2020-03-31 | $21.69M | 1.10% |
| 2019-12-31 | $21.45M | -1.36% |
| 2019-09-30 | $21.75M | -3.28% |
| 2019-06-30 | $22.48M | -1.30% |
| 2019-03-31 | $22.78M | 7.32% |
| 2018-12-31 | $21.23M | 2.51% |
| 2018-09-30 | $20.70M | -1.57% |
| 2018-06-30 | $21.04M | 0.27% |
| 2018-03-31 | $20.98M | 4.02% |
| 2017-12-31 | $20.17M | 4.31% |
| 2017-09-30 | $19.33M | -7.45% |
| 2017-06-30 | $20.89M | 4.41% |
| 2017-03-31 | $20.01M | 8.72% |
| 2016-12-31 | $18.40M | -1.77% |
| 2016-09-30 | $18.73M | -0.19% |
| 2016-06-30 | $18.77M | 0.81% |
| 2016-03-31 | $18.62M | 1.36% |
| 2015-12-31 | $18.37M | 4.30% |
| 2015-09-30 | $17.61M | 4.34% |
| 2015-06-30 | $16.88M | -1.28% |
| 2015-03-31 | $17.10M | 0.02% |
| 2014-12-31 | $17.09M | -4.97% |
| 2014-09-30 | $17.98M | 5.64% |
| 2014-06-30 | $17.02M | -0.09% |
| 2014-03-31 | $17.04M | -3.23% |
| 2013-12-31 | $17.61M | 4.62% |
| 2013-09-30 | $16.83M | -8.41% |
| 2013-06-30 | $18.38M | 57.84% |
| 2013-03-31 | $11.64M | 21.11% |
| 2012-12-31 | $9.61M | 1.07% |
| 2012-09-30 | $9.51M | -13.48% |
| 2012-06-30 | $10.99M | 15.52% |
| 2012-03-31 | $9.52M | 2.02% |
| 2011-12-31 | $9.33M | -2.91% |
| 2011-09-30 | $9.61M | 23.52% |
| 2011-06-30 | $7.78M | -10.12% |
| 2011-03-31 | $8.65M | 7.92% |
| 2010-12-31 | $8.02M | -7.67% |
| 2010-09-30 | $8.69M | 1.01% |
| 2010-06-30 | $8.60M | 14.43% |
| 2010-03-31 | $7.51M | -8.51% |
| 2009-12-31 | $8.21M | 9.64% |
| 2009-09-30 | $7.49M | -27.91% |
| 2009-06-30 | $10.39M | -7.68% |
| 2009-03-31 | $11.26M | -0.30% |
| 2008-12-31 | $11.29M | 66.42% |
| 2008-09-30 | $6.78M | -16.74% |
| 2008-06-30 | $8.15M | 0.95% |
| 2008-03-31 | $8.07M | -24.43% |
| 2007-12-31 | $10.68M | - |
FONAR generated $25.72M in revenue during Q3 2024, up 1.31% compared to the previous quarter, and up 106.03% compared to the same period a year ago.
FONAR Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SHC | Sotera Health Company | $1.05B | $276.59M |
| GTH | Genetron | $650.71M | $201.32M |
| BNR | Burning Rock Biotech | $537.43M | $125.62M |
| LMDX | LumiraDx | $254.48M | $21.00M |
| CSTL | Castle Biosciences | $219.79M | $87.00M |
| OLK | Olink AB (publ) | $169.91M | $28.59M |
| FONR | FONAR | $98.65M | $25.72M |
| STIM | Neuronetics | $71.35M | $16.45M |
| XGN | Exagen | $52.55M | $15.06M |
| BDSX | Biodesix | $49.09M | $14.82M |
| ENZ | Enzo Biochem | $31.06M | $8.02M |
| SERA | Sera Prognostics | $306.00K | - |
FONR Revenue FAQ
What is FONAR’s yearly revenue?
FONAR's yearly revenue for 2023 was $98.65M, representing an increase of 1.08% compared to 2022. The company's yearly revenue for 2022 was $97.59M, representing an increase of 8.52% compared to 2021. FONR's yearly revenue for 2021 was $89.93M, representing an increase of 4.95% compared to 2020.
What is FONAR’s quarterly revenue?
FONAR's quarterly revenue for Q3 2024 was $25.72M, a 1.31% increase from the previous quarter (Q2 2024), and a 1.16% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $25.39M, a 1154.87% increase from the previous quarter (Q1 2024), and a 4.66% increase year-over-year (Q2 2023). FONR's quarterly revenue for Q1 2024 was $2.02M, a -92.15% decrease from the previous quarter (Q4 2023), and a -91.28% decrease year-over-year (Q1 2023).
What is FONAR’s revenue growth rate?
FONAR's revenue growth rate for the last 3 years (2021-2023) was 9.69%, and for the last 5 years (2019-2023) was 13.13%.